21 Participants Needed

ENGAGE Intervention for Post-COVID Support in People With Disabilities

JH
JK
Overseen ByJessica Kersey, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the idea that ENGAGE Intervention for Post-COVID Support in People With Disabilities (also known as: ENGAGE) is an effective treatment?

The available research does not provide specific data on the effectiveness of the ENGAGE Intervention for Post-COVID Support in People With Disabilities. The studies mentioned focus on other treatments and approaches for post-COVID conditions, such as the REGAIN program and various rehabilitation strategies. Without direct data on ENGAGE, it's not possible to compare its effectiveness to other treatments based on the information provided.12345

What data supports the effectiveness of the ENGAGE treatment for post-COVID support in people with disabilities?

While there is no direct data on the ENGAGE treatment, similar rehabilitation programs have been shown to help people recover from ongoing COVID-19 symptoms by providing structured exercise and psychological support, which are key components in aiding recovery.12345

What safety data exists for the ENGAGE treatment for post-COVID support in people with disabilities?

The provided research does not contain specific safety data for the ENGAGE treatment or any related interventions for post-COVID support in people with disabilities. The studies focus on different support interventions during the COVID-19 pandemic, such as peer-based support in prisons, postdiagnostic dementia support, trends in drug-related deaths, managed alcohol programs for homelessness, and a bereavement support line. None of these directly evaluate the safety of the ENGAGE treatment.678910

Is the ENGAGE treatment a promising treatment for people with disabilities after COVID?

Yes, the ENGAGE treatment is promising because it focuses on peer support, which can help people with disabilities who have long COVID by providing mutual support and advocacy, especially for those who might not access traditional healthcare services.111121314

How is the ENGAGE treatment for post-COVID support in people with disabilities different from other treatments?

The ENGAGE treatment is unique because it focuses on peer support, which involves people with similar experiences helping each other, rather than just traditional medical approaches. This can be especially beneficial for those who are marginalized and may not access standard healthcare services, offering a more inclusive and community-based support system.111121314

Research Team

JH

Joy Hammel, PhD

Principal Investigator

University of Illinois Chicago

Eligibility Criteria

This trial is for English-speaking individuals with disabilities who feel socially isolated, especially due to the pandemic. They must live in a community setting and be able to express their interest in participating verbally. People with severe communication impairments that limit this ability cannot join.

Inclusion Criteria

You report issues with engaging in social activities.
Speak English
You identify yourself as having a disability.
See 1 more

Exclusion Criteria

You have difficulty communicating and may not be able to express your interest in participating in the study.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in the ENGAGE intervention, which uses social learning, guided problem-solving, and applied skill training to promote social participation among people with disabilities

8 weeks

Follow-up

Participants are monitored for retention and adherence, with follow-up assessments to evaluate intervention feasibility and satisfaction

4 weeks

Treatment Details

Interventions

  • ENGAGE
Trial OverviewThe study is testing ENGAGE, an intervention aimed at reducing social isolation among people with disabilities post-COVID. It's a preliminary study focusing on how well the program works in terms of attracting and keeping participants, as well as its impact on improving social involvement.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ENGAGEExperimental Treatment1 Intervention
ENGAGE uses social learning, guided problem-solving and applied skill training to promote social participation among people with disabilities within the context of the COVID-19 pandemic. This is a group intervention using a self-management framework.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

National Center for Advancing Translational Sciences (NCATS)

Collaborator

Trials
394
Recruited
404,000+

Findings from Research

A study of 100 participants with post-COVID syndrome revealed significant impairments in various body functions, particularly in fatigability (98-99%), higher cognitive functions (74-94%), and sleep functions (98%).
Participants also experienced major limitations in daily activities, such as handling stressful situations (98%) and engaging in recreational activities (94%), highlighting the need for a multidisciplinary rehabilitation approach to support recovery.
Self-scored impairments in functioning and disability in post-COVID syndrome following mild COVID-19 infection.Norrefalk, JR., Borg, K., Bileviciute-Ljungar, I.[2022]
The study aims to compare the effectiveness and cost-effectiveness of an eight-week online rehabilitation program (REGAIN) versus a single online consultation for adults experiencing ongoing COVID-19 symptoms more than three months after hospital discharge, involving 535 participants.
The primary outcome measured will be health-related quality of life, assessed at three months post-randomization, with secondary outcomes including physical and mental health indicators evaluated at three, six, and twelve months.
Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN' (REGAIN): a structured summary of a study protocol for a randomised controlled trial.McGregor, G., Sandhu, H., Bruce, J., et al.[2022]
This study evaluates a comprehensive treatment program for post-acute COVID-19 syndrome (PACS) involving online screening and personalized support, aiming to improve diagnosis and recovery for patients.
Participants will be divided into groups receiving different levels of assessment and digital interventions, with the primary focus on symptom reduction and return to work, making it one of the first large-scale efforts to address PACS effectively.
Screening and assessment for post-acute COVID-19 syndrome (PACS), guidance by personal pilots and support with individual digital trainings within intersectoral care: a study protocol of a randomized controlled trial.Dahmen, A., Keller, FM., Derksen, C., et al.[2022]

References

Self-scored impairments in functioning and disability in post-COVID syndrome following mild COVID-19 infection. [2022]
Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN' (REGAIN): a structured summary of a study protocol for a randomised controlled trial. [2022]
Screening and assessment for post-acute COVID-19 syndrome (PACS), guidance by personal pilots and support with individual digital trainings within intersectoral care: a study protocol of a randomized controlled trial. [2022]
British Thoracic Society survey of rehabilitation to support recovery of the post-COVID-19 population. [2021]
Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. [2022]
Exploring the Potential of Implementing Managed Alcohol Programmes to Reduce Risk of COVID-19 Infection and Transmission, and Wider Harms, for People Experiencing Alcohol Dependency and Homelessness in Scotland. [2022]
Implementation and evaluation of a National Bereavement Support line in response to the COVID-19 pandemic in Ireland. [2023]
Delivering Peer-Based Support in Prisons During the COVID Pandemic and Lockdown: Innovative Activities Delivered by People Who Care. [2022]
Changes to postdiagnostic dementia support in England and Wales during the COVID-19 pandemic: a qualitative study. [2022]
Trends in deaths following drug use in England before, during, and after the COVID-19 lockdowns. [2023]
Towards evidence-based and inclusive models of peer support for long covid: A hermeneutic systematic review. [2023]
Assessing the Acceptability of a Co-Produced Long COVID Intervention in an Underserved Community in the UK. [2022]
Effectiveness and cost-effectiveness of a personalised self-management intervention for living with long COVID: protocol for the LISTEN randomised controlled trial. [2023]
Implementing psychological support for health and social care staff affected by the COVID-19 pandemic: a qualitative exploration of staff well-being hubs ('Resilience Hubs') using normalisation process theory. [2023]